Markers of tumor invasion are major predictive factors for the long-term outcome of corticotroph microadenomas treated by transsphenoidal adenomectomy.
Vallette-Kasic, S.; Dufour, H.; Mugnier, M.et al.
2000 • In European Journal of Endocrinology, 143 (6), p. 761-8
Adenoma/pathology/surgery; Adolescent; Adrenocorticotropic Hormone/blood; Adult; Female; Humans; Hydrocortisone/blood; Hypophysectomy/methods; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Invasiveness/pathology; Pituitary Neoplasms/pathology/surgery; Predictive Value of Tests; Treatment Outcome; Tumor Markers, Biological/analysis
Abstract :
[en] OBJECTIVE: To assess the postsurgical outcome of patients with corticotroph microadenomas and to define predictors of the long-term outcome, with special emphasis on markers of tumor extension. DESIGN: Prospective study of 53 corticotroph microadenomas treated by enlarged adenomectomy. Patients followed for at least 2 years were classified into two groups: those in long-term remission and uncured patients (immediate failures and recurrences). Pre-, per- and postoperative parameters were analyzed as predictors of the long-term outcome. METHODS: Baseline hormone assessments were performed preoperatively, 8 days after surgery and every 6-12 months thereafter. Pituitary magnetic resonance imaging (MRI) allowed analysis of possible tumor extension to adjacent structures. Apparent completeness of the surgical removal was determined, and fragments labeled either 'tumor' or 'surrounding pituitary tissue' were submitted to serial sectioning. RESULTS: Immediate control of hypercortisolism was achieved in 43/53 patients (81%). However, later recurrences were observed in five patients (9%). Preoperative MRI showed tumor extension into adjacent structures with good specificity (91%) for prediction of surgical failure. Evidence of local invasion at surgery was also significantly predictive of the long-term outcome. A corticotroph adenoma was found at histological examination in 96% of the patients, and 26% had irregular limits, a feature significantly correlated with a poor outcome. Immediate postoperative plasma cortisol did not allow discrimination between long-term remissions and recurrences. CONCLUSION: Surgical failure was best predicted by signs of tumor 'invasiveness' at MRI, confirmed by peroperative examination and histology.
Markers of tumor invasion are major predictive factors for the long-term outcome of corticotroph microadenomas treated by transsphenoidal adenomectomy.
Bochicchio D., Losa M., Buchfelder M. (1995) Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: A retrospective study by the European Cushing's disease survey study group. Journal of Clinical Endocrinology and Metabolism 80:3114-3120.
Extabe J., Vazquez J.A. (1994) Morbidity and mortality in Cushing's disease: An epidemiologic approach. Clinical Endocrinology 40:479-484.
Hardy J. (1969) Transsphenoidal microsurgery of the normal and pathological pituitary. Clinical Neurosurgery 16:185-217.
Boggan J.E., Tyrrell J.B., Wilson C.B. (1983) Transsphenoidal microsurgical management of Cushing's disease. Report of 100 cases. Journal of Neurosurgery 59:195-200.
Tyrrell J.B., Brooks R.M., Fitzgerald P.A., Cofoid P.B., Forsham P.H., Wilson C.B. (1978) Cushing's disease selective transsphenoidal resection of pituitary microadenomas. New England Journal of Medicine 298:753-758.
Barrou Z., Abecassis J.P., Guilhaume B., Thomopoulos P., Bertagna X., Derome P. (1997) Magnetic resonance imaging: Prediction of surgical outcome. Presse Médicale (Paris) 26:7-11.
Guilhaume B., Bertagna X., Thomsen M., Bricaire C., Vila-Porcile E., Olivier L. (1988) Transsphenoidal pituitary surgery for the treatment of Cushing's disease: Results in 64 patients and long term follow-up studies. Journal of Clinical Endocrinology and Metabolism 66:1056-1064.
Nakane T., Kuwayama A., Watanabe M., Takahashi T., Kato T., Ichihara K. (1987) Long term results of transsphenoidal adenomectomy in patients with Cushing's disease. Neurosurgery 21:218-222.
Orth D.N. (1995) Medical progress: Cushing's syndrome. New England Journal of Medicine 332:791.
Robert F., Hardy J. (1991) Cushing's disease: A correlation of radiological, surgical and pathological finding with therapeutic results. Pathology, Research and Practice 187:617-621.
Tagliaferri M., Berselli M.E., Loli P. (1986) Transsphenoidal microsurgery for Cushing's disease. Acta Endocrinologica 113:5-11.
Invitti C., Pecori Giraldi F., De Martin M., Cavagnini F. (1999) Diagnosis and management of Cushing's syndrome: Results of an Italian multicentre study. Journal of Clinical Endocrinology and Metabolism 84:440-448.
Burke C.W., Adams C.B., Esiri M.M., Morris C., Bevan J.S. (1990) Transsphenoidal surgery for Cushing's disease: Does what is removed determine the endocrine outcome?. Clinical Endocrinology 33:525-537.
Lamberts S.W., Klijn J.G., De Jong F.H. (1987) The definition of true recurrence of pituitary-dependent Cushing's syndrome after transsphenoidal operation. Clinical Endocrinology 26:707-712.
Nishizawa S., Oki Y., Ohta S., Yokota N., Yokoyama T., Uemura K. (1999) What can predict postoperative 'endocrinological cure' in Cushing's disease?. Neurosurgery 45:239-244.
McCance D.R., Gordon D.S., Fannin T.F., Hadden D.R., Kennedy L., Sheridan B. (1993) Assessment of endocrine function after transsphenoidal surgery for Cushing's disease. Clinical Endocrinology 38:79-86.
McCance D.R., Besser M., Atkinson A.B. (1996) Assessment of cure after transsphenoidal surgery for Cushing's disease. Clinical Endocrinology 44:1-6.
Trainer P.J., Lawrie H.S., Verhelst J., Howlett T.A., Lowe D.G., Grossman A.B. (1993) Transsphenoidal resection in Cushing's disease: Undetectable serum cortisol as the definition of successful treatment. Clinical Endocrinology 38:73-78.
Jeffcoate W.J., Qawncey S., Selby C. (1985) Restauration of dexamethasone suppression by incomplete adenomectomy in Cushing's disease. Clinical Endocrinology 23:193-199.
Schrell U., Fahlbusch R., Buchfelder M., Riedl S., Stalla G.K., Muller O.A. (1987) Corticotropin-releasing hormone stimulation test before and after transsphenoidal selective microadenomectomy in 30 patients with Cushing's disease. Journal of Clinical Endocrinology and Metabolism 64:1150-1159.
Grisoli F., Brue T., Graziani N., Costa R., Trouillas J., Begou D. (1990) Enlarged adenomectomy for enclosed prolactinomas: A preliminary study of 26 cases. Acta Neurochirurgica (Wien) 103:92-98.
Newell-Price J., Trainer E., Besser M., Grossman A. (1998) The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocrine Reviews 19:647-672.
Trouillas J., Guigard M.P., Souchier C., Girod C. (1996) Mapping of corticotropic cells in the normal human pituitary. Journal of Histochemistry and Cytochemistry 82:473-479.
Girard N., Mugnier M., Dufour H., Trouillas J., Brue T., Raybaud C. (1997) Magnetic resonance imaging findings in Cushing disease. International Journal of Neuroradiology 3:319-326.
Devoe D.J., Miller W.L., Conte F.A., Kaplan S.L., Grumbach M.M., Rosenthal S.M. (1997) Long-term outcome in children and adolescents after transsphenoidal surgery for Cushing's disease. Journal of Clinical Endocrinology and Metabolism 82:3196-3202.
Leinung M.C., Kane L.A., Scheithauer B.W., Carpenter P.C., Laws E.R. Jr., Zimmerman D. (1995) Long term follow-up of transsphenoidal surgery for the treatment of Cushing's disease in childhood. Journal of Clinical Endocrinology and Metabolism 80:2475-2479.
Toms G.C., McCarthy M.I., Niven M.J., Orteu C.H., King T.T., Monson J.P. (1993) Predicting relapse after transsphenoidal surgery for Cushing's disease. Journal of Clinical Endocrinology and Metabolism 76:291-294.
Pieters G.F., Hermus A.R., Meijer E., Smals A.G., Kloppenborg P.W. (1989) Predictive factors for initial cure and relapse rate after pituitary surgery for Cushing's disease. Journal of Clinical Endocrinology and Metabolism 69:1122-1126.
Mampalam T.J., Tyrrell J.B., Wilson C.B. (1988) Transsphenoidal microsurgery for Cushing disease. A report of 216 cases. Annals of Internal Medicine 109:487-493.
Newell-Price J., Perry L., Medbak S., Monson J., Savage M., Besser M. (1997) A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 82:176-181.
Bakiri F., Tatai S., Aouali R., Semrouni M., Derome P., Chitour F. (1996) Treatment of Cushing's disease by transsphenoidal, pituitary microsurgery: Prognosis factors and long-term follow-up. Journal of Endocrinological Investigation 19:572-580.